Identify platinum-resistant ovarian cancer patients using EV-miRNA markers in body fluids and treat them with JAK inhibitors.
Tsukuba System: World's strongest vector for transient protein expression with a yield of 4 mg/g
Platform technology for next generation displays that enables RGB on/off by controlling the “Droplet laser” on the substrate with an electric field
A new concept in therapeutics targeting molecules associated with vascular inflammation
Novel targets identified from genetic analysis of a model animal and patients that differ from previous therapeutic approaches
Predicting therapeutic efficacy of combined immunotherapy such as atezolizumab/bevacizumab using CD14+ monocyte/CD4+ T cell subsets as an indicator
Novel target molecules of the ergosterol synthesis pathway, a critical gene for Candida
Novel HPV risk classification method utilizing amino acid sequence/mutations in E6 protein as a marker
Cell membrane-derived vesicles of target bacteria can be used to develop activation products for specific enteric bacteria and antibacterial agents against biofilm-producing bacteria
Using vesicles derived from the cell membrane of target bacteria allows for highly species-specific treatment